Saturday, March 18, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Featured News

FDA Medical Countermeasures Initiative Symposium

by Global Biodefense Staff
June 1, 2014
Medical Countermeasures Research for Biodefense

Credit: Shutterstock

MCMi Regulatory Science Symposium PosterFDA’s Medical Countermeasures initiative (MCMi) will host their annual Regulatory Science Symposium this week at FDA Headquarters in Silver Springs, Md.

The goals of the event are to exchange ideas on countermeasure development; highlight work on regulatory science as it applies to developing and advancing medical countermeasures; facilitate innovative directions; and inform stakeholders on related scientific progress and achievements.

Registration for in-person attendance is closed, however the event will also be webcast live and program materials made available at no charge.

Highlighted topics include:

  • Animal Models, Biomarkers & Correlates of Protection
  • Advancing Technologies for Product Characterization
  • Massively parallel sequencing for monitoring genetic variability of seed viruses for influenza vaccine
  • Evaluation of New Technology Multiplex Tests for Detection of Emerging and Blood Borne Pathogens
  • Challenges of a pediatric product in stockpiling: Feasibility studies with a pediatric product of oseltamivir phosphate
  • The influence of device design in cleaning biological and chemical contaminants from reusable medical devices
  • Animal Model Development for Eczema Vaccinatum, a Life-Threatening Smallpox Vaccine Complication
  • Role of natural killer cells against influenza in presence of humanized monoclonal antibodies
  • Systems pharmacology for assessing and understanding drug safety
  • The Pathogenesis and Management of Anthrax Sepsis and Septic Shock: Studies in Small and Large Animal Models
  • Novel nanoparticle and microfluidics approaches for detection of viral pathogens in laboratory based and point-of-care settings
  • Evaluation of New Technology Multiplex Tests for Detection of Emerging and Blood Borne Pathogens
  • Rapid and comprehensive detection of antimicrobial resistance in bacterial pathogens
  • Enabling sequence-based technologies for microbial countermeasures and clinical diagnostics
  • Handheld Automated Notification for Drugs and Immunizations (HANDI)
  • The BARDA Clinical Study Network’s Role in MCM Surveillance
  • Real-time Application for Portable Interactive Devices
  • Harnessing electronic medical records for MCM Surveillance

Please visit the FDA’s MCMi Regulatory Science Symposium website for more information. Follow symposium updates on Twitter by searching #FDARegSci, and follow MCMi at @FDA_MCMi.

Tags: Animal ModelsAntimicrobialsAntitoxinsAntiviralsASPRBARDABiomarkersBioterrorismChemical DetectionEventsHHSPOC DiagnosticsStrategic National StockpileThermostabilityVaccines

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
small glass vials on an assembly line await filling of vaccine solution
Industry News

Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding

January 12, 2023
How Are Bivalent COVID Vaccines Stacking Up Against Omicron?
Infectious Diseases

How Are Bivalent COVID Vaccines Stacking Up Against Omicron?

January 12, 2023
Load More

Latest News

Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC